Oral granisetron alone and in combination with dexamethasone: A double-blind randomized comparison against high-dose metoclopramide plus dexamethasone in prevention of cisplatin-induced emesis

Coates, 1983, On the receiving end – patient perception of the side effect of cancer chemotherapy, Eur J Cancer Clin Oncol, 19, 203, 10.1016/0277-5379(83)90418-2 Hesketh, 1991, Serotonin antagonists: A new class of antiemetic agents, J Natl Cancer Inst, 83, 611, 10.1093/jnci/83.9.613 1993, The control of acute cisplatin-induced emesis – a comparative study of granisetron and a combination regimen of high-dose metclopramide and dexamethasone, Br J Cancer, 68, 176, 10.1038/bjc.1993.309 1994, A dose-finding study of granisetron, a novel antiemetic, in patients receiving high-dose cisplatin, Supp Care Cancer, 3, 177 1993, A dose-finding study of granisetron, a novel antiemetic, in patients receiving cytostatic chemotherapy, J Cancer Res Clin Oncol, 119, 350, 10.1007/BF01208844 Marty, 1990, A comparative study of the use of Granisetron, a selective 5-HT3 antagonist, versus a standard anti-emetic regimen of chlorpromazine plus dexamethasone in the treatment of cytostatic-induced emesis, Eur J Cancer, 26, S28 Hacking, 1992, Oral granisetron – simple and effective: A preliminary report, Eur J Cancer, 28A, S28, 10.1016/0959-8049(92)90633-D Aapro, 1991, Controlling emesis related to cancer therapy, Eur J Cancer, 27, 356, 10.1016/0277-5379(91)90545-O Seynaeve, 1991, Controlling cancer chemotherapy-induced emesis, Pharm Weekbl Scientific Edition, 13, 189, 10.1007/BF01988874 Latreille, 1993, Dexamethasone improves the efficacy of granisetron in the first 24 hours following high dose cisplatin chemotherapy, Proc ASCO, 12, 133 Carmichael, 1993, IV granisetron versus IV granisetron plus i.v. dexamethasone in the prophylaxis of emesis induced by cytotoxic chemotherapy, Eur J Cancer, 29A, S206, 10.1016/0959-8049(93)91773-E Allan, 1984, Dexamethasone and high-dose metoclopramide: Efficacy in controlling cisplatin induced nausea and vomiting, Br Med J, 289, 878, 10.1136/bmj.289.6449.878-a ABPI Datasheet Compendium 1989–1990. Tonato, 1991, Methodology of antiemetic trials: A review, Ann Oncol, 2, 107, 10.1093/oxfordjournals.annonc.a057871 Kaye, 1992, Who should receive a 5-HT3 antagonist?, Lancet, 340, 1107, 10.1016/0140-6736(92)93138-D Roila, 1991, Predictive factors of delayed emesis in cisplatin treated patients and anti-emetic activity and tolerability of metoclopramide or dexamethasone, Am J Clin Oncol (CCT), 14, 238, 10.1097/00000421-199106000-00010 De Mulder, 1990, Ondansetron compared with high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting: A multicenter, randomised, double-blind, cross-over study, Ann Intern Med, 113, 834, 10.7326/0003-4819-113-11-834 Kris, 1989, Controlling delayed vomiting: Double-blind randomised trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin, J Clin Oncol, 7, 108, 10.1200/JCO.1989.7.1.108